Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers

NCT03162042 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT03162042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Observational
Overall status
Completed
Start date
November 2, 2015
Completion date
May 31, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia, head and neck cancer, squamous cell carcinoma